Dopamine agonist therapy for Parkinson disease and pathological gambling

Akiko Imamura, Ryan J. Uitti, Zbigniew K Wszolek

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

We report 6 patients with pathological gambling during pharmacologic treatment for Parkinson disease (PD). Four patients were treated with levodopa/carbidopa and dopamine agonist (DA), and 2 patients received DA monotherapy. We reviewed several published reports regarding pathological gambling and antiparkinsonian therapy and suggest that more advanced PD and antiparkinsonian combination therapy (e.g., levodopa/carbidopa and DA) increases the risk for development of pathological gambling behavior compared with monotherapy with either DA or levodopa/carbidopa.

Original languageEnglish (US)
Pages (from-to)506-508
Number of pages3
JournalParkinsonism and Related Disorders
Volume12
Issue number8
DOIs
StatePublished - Dec 2006

Fingerprint

Gambling
Dopamine Agonists
Parkinson Disease
Antiparkinson Agents
Therapeutics
levodopa drug combination carbidopa

Keywords

  • Dopamine agonist
  • Levodopa
  • Parkinson disease
  • Pathological gambling

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Neurology

Cite this

Dopamine agonist therapy for Parkinson disease and pathological gambling. / Imamura, Akiko; Uitti, Ryan J.; Wszolek, Zbigniew K.

In: Parkinsonism and Related Disorders, Vol. 12, No. 8, 12.2006, p. 506-508.

Research output: Contribution to journalArticle

@article{8bb698204a494f95bbbe0b7dd3149baa,
title = "Dopamine agonist therapy for Parkinson disease and pathological gambling",
abstract = "We report 6 patients with pathological gambling during pharmacologic treatment for Parkinson disease (PD). Four patients were treated with levodopa/carbidopa and dopamine agonist (DA), and 2 patients received DA monotherapy. We reviewed several published reports regarding pathological gambling and antiparkinsonian therapy and suggest that more advanced PD and antiparkinsonian combination therapy (e.g., levodopa/carbidopa and DA) increases the risk for development of pathological gambling behavior compared with monotherapy with either DA or levodopa/carbidopa.",
keywords = "Dopamine agonist, Levodopa, Parkinson disease, Pathological gambling",
author = "Akiko Imamura and Uitti, {Ryan J.} and Wszolek, {Zbigniew K}",
year = "2006",
month = "12",
doi = "10.1016/j.parkreldis.2006.02.004",
language = "English (US)",
volume = "12",
pages = "506--508",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "8",

}

TY - JOUR

T1 - Dopamine agonist therapy for Parkinson disease and pathological gambling

AU - Imamura, Akiko

AU - Uitti, Ryan J.

AU - Wszolek, Zbigniew K

PY - 2006/12

Y1 - 2006/12

N2 - We report 6 patients with pathological gambling during pharmacologic treatment for Parkinson disease (PD). Four patients were treated with levodopa/carbidopa and dopamine agonist (DA), and 2 patients received DA monotherapy. We reviewed several published reports regarding pathological gambling and antiparkinsonian therapy and suggest that more advanced PD and antiparkinsonian combination therapy (e.g., levodopa/carbidopa and DA) increases the risk for development of pathological gambling behavior compared with monotherapy with either DA or levodopa/carbidopa.

AB - We report 6 patients with pathological gambling during pharmacologic treatment for Parkinson disease (PD). Four patients were treated with levodopa/carbidopa and dopamine agonist (DA), and 2 patients received DA monotherapy. We reviewed several published reports regarding pathological gambling and antiparkinsonian therapy and suggest that more advanced PD and antiparkinsonian combination therapy (e.g., levodopa/carbidopa and DA) increases the risk for development of pathological gambling behavior compared with monotherapy with either DA or levodopa/carbidopa.

KW - Dopamine agonist

KW - Levodopa

KW - Parkinson disease

KW - Pathological gambling

UR - http://www.scopus.com/inward/record.url?scp=33751232650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751232650&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2006.02.004

DO - 10.1016/j.parkreldis.2006.02.004

M3 - Article

C2 - 16723269

AN - SCOPUS:33751232650

VL - 12

SP - 506

EP - 508

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 8

ER -